About Us

Text size
view with small font size
view with medium font size
view with large font size

Mission

  1. Therapeutic Antibody Technologies Out-Licensing
    • POTELLIGENT® Technology for ADCC-enhancement of therapeutic antibodies
    • COMPLEGENT ® Technology for CDC-enhancement of therapeutic antibodies
    • AccretaMab ® (Combination of POTELLIGENT ® and COMPLEGENT ® )

To Page Top